Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Hong Kong
Incorporation of anthracyclines into chemotherapy protocols has improved the survival of children with solid tumours and haematological malignancies. Nonetheless, longitudinal studies have implicated the absence of a safe anthracycline dose that is free of cardiotoxicity. Substantial risk for cardiovascular disease has been shown recently in large cohorts of adult survivors of childhood and adolescent survivors. Serial monitoring of cardiac function is hence of paramount importance in childhood cancer survivors for early detection of myocardial damage and timely institution of interventions. The optimal monitoring of cardiac function in the long term in these at-risk patients remains to be established. Novel noninvasive imaging modalities including echocardiography and cardiac magnetic resonance allow interrogation of myocardial deformation and fibrosis, while circulating biomarkers are increasingly used to monitor the cardiac status in heart failure patients. Additionally, genetics of heart failure are increasingly unveiled.
Age
18–35
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
patients aged 18 to 35 years old
history of acute leukaemia diagnosed before 18 years old
completion of cancer directed therapy for at least 5 years.
You may not be if
history of congenital heart disease
presence of syndromal disorder such as Down syndrome, neurofibromatosis, etc,
hypothyroidism not on replacement therapy
claustrophobia or other reasons rendering MRI assessment not feasible.